PAK2 and neoplasm: Although the mechanism by which Pak2 serves as a signaling intermediate in regulating the balance between Treg immunosuppression and immunopathology warrants further investigation, these insights would be therapeutically significant for multiple diseases, including Th2-mediated allergic hypersensitivity, autoimmunity and tumor immunology.